Author

Fran Supek

Primary ORCID profile (0000-0002-7811-6711 · 24 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Fran SupekiD24 papers · Institució Catalana de Recerca i Estudis Avançats

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ana JaniciD· 1 shared Anna Benito· 1 shared Carlos Manuel MartíneziD· 1 shared Davor Orsolic· 1 shared Dimitri Kounis· 1 shared Elisabetta MereuiD· 1 shared Etna AbadiD· 1 shared Guillermo Palou Márquez· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana JanicORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual inhibition of the nonsense mediated mRNA decay enhances tumour immunogenicity, drives immunoediting, and potentiates checkpoint blockade

Ivan Zadra, Davor Orsolic, Dimitri Kounis, Mario Acera Mateos, Guillermo Palou Márquez, Etna Abad, Laura Ortet, Anna Benito, Yacine Kharraz, Carlos Manuel Martínez, Elisabetta Mereu, Fran Supek, Ana Janic

This study shows that inhibiting nonsense-mediated mRNA decay enhances tumour immunogenicity, drives immunoediting, and improves checkpoint blockade efficacy in preclinical models.

bioRxiv · Dec 8, 2025 · PreprintCancer Biology